Urine-Based Cell-Free DNA Tests in Urothelial Cancer: Additional Value for Clinical Decision-Making?
None.
Príomhchruthaitheoir: | Lars Dyrskjøt |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
The Société Internationale d’Urologie (SIU)
2023-07-01
|
Sraith: | Société Internationale d’Urologie Journal |
Ábhair: | |
Rochtain ar líne: | https://siuj.org/index.php/siuj/article/view/289/238 |
Míreanna comhchosúla
Míreanna comhchosúla
-
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
de réir: Hongwei Peng, et al.
Foilsithe / Cruthaithe: (2024-05-01) -
Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals
de réir: Kerstin Lang, et al.
Foilsithe / Cruthaithe: (2024-11-01) -
Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
de réir: Sander Bach, et al.
Foilsithe / Cruthaithe: (2022-10-01) -
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection
de réir: Naheema S. Gordon, et al.
Foilsithe / Cruthaithe: (2024-11-01) -
The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
de réir: Ivonne Nel, et al.
Foilsithe / Cruthaithe: (2023-12-01)